On October 5, 2023, Treatment.Com International Inc. closed the transaction. The company amended the terms of the transaction and issued 2,475,000 common shares in the capital of the company at a price of CAD 0.15 per common share, for aggregate gross proceeds of up to CAD 371,250. The company has received CAD 350,234 pursuant to Regulation D and included participation from 2 investors.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.55 CAD | +5.77% | -5.17% | +29.41% |
1st Jan change | Capi. | |
---|---|---|
+29.41% | 14.93M | |
+6.03% | 32.93B | |
+18.24% | 7.94B | |
+30.15% | 4.19B | |
-26.79% | 2.8B | |
-17.27% | 1.38B | |
-33.33% | 1.17B | |
+9.84% | 966M | |
-37.56% | 900M | |
-26.60% | 839M |
- Stock Market
- Equities
- TRUE Stock
- News Treatment.com AI Inc.
- Treatment.Com International Inc. announced that it has received CAD 0.37125 million in funding